Skip to main navigation

Site - Top main nav

Patients & Caregivers
- About HAE
Healthcare Professionals
Clinical Trials
Presentations & Publications
Investors & News

Site - Top Secondary nav

About
Science
Pipeline
Careers
- Careers
- Job Openings
Contact

Investment Calculator

Site - Top main nav

Patients & Caregivers
- About HAE
Healthcare Professionals
Clinical Trials
Presentations & Publications
Investors & News

Status message

Data is not available prior to November 22, 2016. Please select a new date.

Investment Month

Investment Day

Investment Year

Investment

Units

Leave this field blank

Initial Investment on Nov 22, 2016

Original Shares:

1,000.00

Original Value:

$599.30

Current Shares:

71.43

Current Value:

$739.30

Current Price:

$10.35

Split Adjustment:

0.07143

23.36% Return

Return calculations do not include reinvested cash dividends.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Site - Shareholder tools

Print Page

Email Alerts

RSS

IR Contacts

Search

Site - Top Secondary nav

About

Senior Management

Board of Directors

Science

Pipeline

Oral Factor XIIa Inhibitor

Careers

Contact

Site - Legal links

KalVista Terms of Use Privacy Policy

© 2024 KalVista Pharmaceuticals. All Rights Reserved.